Grifolin exhibits anti-cancer activity by inhibiting the development and invasion of gastric tumor cells

Zijian Wu; Ying Li

doi:10.18632/oncotarget.15250

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Grifolin exhibits anti-cancer activity by inhibiting the development and invasion of gastric tumor cells

Zijian Wu _ and Ying Li

PDF | HTML | How to cite

Oncotarget. 2017; 8:21454-21460. https://doi.org/10.18632/oncotarget.15250

Metrics: PDF 1474 views | HTML 2206 views | ?

Abstract

Zijian Wu1, Ying Li2

1Tianjin Key Laboratory of Food Biotechnology, College of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin, China

2Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China

Correspondence to:

Zijian Wu, email: [email protected]

Ying Li, email: [email protected]

Keywords: gastric cancer, grifolin, natural anti-cancer product, apoptosis, cancer invasion

Received: October 20, 2016 Accepted: November 24, 2016 Published: February 10, 2017

ABSTRACT

Grifolin, a natural product isolated from the mushroom Albatrellus confluens, has been reported to be a potent anti-cancer agent in nasopharyngeal carcinoma and osteosarcoma. The data obtained in this study revealed that grifolin is capable of inhibiting the growth and invasion of gastric cancer cells by inducing apoptosis and suppressing the ERK1/2 pathway. Our results support the potent utility of grifolin as an anti-tumor lead compound against gastric cancer cells.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15250

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

Grifolin exhibits anti-cancer activity by inhibiting the development and invasion of gastric tumor cells

Abstract